Durable Remission of Metastatic Renal Cell Carcinoma With Gemcitabine and Capecitabine After Failure of Targeted Therapy

被引：17
作者：
Richey, Stephen L. [1 ]
Ng, Chaan [1 ]
Lim, Zita D. [1 ]
Jonasch, Eric [1 ]
Tannir, Nizar M. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 08期
关键词：
INTERFERON-ALPHA; PHASE-II; CHROMOSOMAL-ABERRATIONS; DOUBLE-BLIND; CANCER; TRIAL;
D O I：
10.1200/JCO.2010.31.6091
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：E203 / E205
页数：3
相关论文
共 18 条
[1]   Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial [J].
Escudier, Bernard ;
Pluzanska, Anna ;
Koralewski, Piotr ;
Ravaud, Alain ;
Bracarda, Sergio ;
Szczylik, Cezary ;
Chevreau, Christine ;
Filipek, Marek ;
Melichar, Bohuslav ;
Bajetta, Emilio ;
Gorbunova, Vera ;
Bay, Jacques-Olivier ;
Bodrogi, Istvan ;
Jagiello-Gruszfeld, Agnieszka ;
Moore, Nicola .
LANCET, 2007, 370 (9605) :2103-2111
[2]   Sorafenib in advanced clear-cell renal-cell carcinoma [J].
Escudier, Bernard ;
Eisen, Tim ;
Stadler, Walter M. ;
Szczylik, Cezary ;
Oudard, Stephane ;
Siebels, Michael ;
Negrier, Sylvie ;
Chevreau, Christine ;
Solska, Ewa ;
Desai, Apurva A. ;
Rolland, Frederic ;
Demkow, Tomasz ;
Hutson, Thomas E. ;
Gore, Martin ;
Freeman, Scott ;
Schwartz, Brian ;
Shan, Minghua ;
Simantov, Ronit ;
Bukowski, Ronald M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (02) :125-134
[3]   INDUCTION OF APOPTOSIS IN FIBROBLASTS BY C-MYC PROTEIN [J].
EVAN, GI ;
WYLLIE, AH ;
GILBERT, CS ;
LITTLEWOOD, TD ;
LAND, H ;
BROOKS, M ;
WATERS, CM ;
PENN, LZ ;
HANCOCK, DC .
CELL, 1992, 69 (01) :119-128
[4]  
HERTEL LW, 1990, CANCER RES, V50, P4417
[5]   Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma [J].
Hudes, Gary ;
Carducci, Michael ;
Tomczak, Piotr ;
Dutcher, Janice ;
Figlin, Robert ;
Kapoor, Anil ;
Staroslawska, Elzbieta ;
Sosman, Jeffrey ;
McDermott, David ;
Bodrogi, Istvan ;
Kovacevic, Zoran ;
Lesovoy, Vladimir ;
Schmidt-Wolf, Ingo G. H. ;
Barbarash, Olga ;
Gokmen, Erhan ;
O'Toole, Timothy ;
Lustgarten, Stephanie ;
Moore, Laurence ;
Motzer, Robert J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (22) :2271-2281
[6]   Upfront, Randomized, Phase 2 Trial of Sorafenib Versus Sorafenib and Low-Dose Interferon Alfa in Patients With Advanced Renal Cell Carcinoma Clinical and Biomarker Analysis [J].
Jonasch, Eric ;
Corn, Paul ;
Pagliaro, Lance C. ;
Warneke, Carla L. ;
Johnson, Marcella M. ;
Tamboli, Pheroze ;
Ng, Chaan ;
Aparicio, Ana ;
Ashe, Robynne G. ;
Wright, John J. ;
Tannir, Nizar M. .
CANCER, 2010, 116 (01) :57-65
[7]   Whole genome SNP arrays as a potential diagnostic tool for the detection of characteristic chromosomal aberrations in renal epithelial tumors [J].
Monzon, Federico A. ;
Hagenkord, Jill M. ;
Lyons-Weiler, Maureen A. ;
Balani, Jyoti P. ;
Parwani, Anil V. ;
Sciulli, Christin M. ;
Li, Jia ;
Chandran, Uma R. ;
Bastacky, Sheldon I. ;
Dhir, Rajiv .
MODERN PATHOLOGY, 2008, 21 (05) :599-608
[8]  
Monzon FA, 2009, ARCH PATHOL LAB MED, V133, P1917, DOI 10.1043/1543-2165-133.12.1917
[9]   Systemic therapy for renal cell carcinoma [J].
Motzer, RJ ;
Russo, P .
JOURNAL OF UROLOGY, 2000, 163 (02) :408-417
[10]   Efficacy of everolimus in advanced renal cell carcinoma:: a double-blind, randomised, placebo-controlled phase III trial [J].
Motzer, Robert J. ;
Escudier, Bernard ;
Oudard, Stephane ;
Hutson, Thomas E. ;
Porta, Camillo ;
Bracarda, Sergio ;
Gruenwald, Viktor ;
Thompson, John A. ;
Figlin, Robert A. ;
Hollaender, Norbert ;
Urbanowitz, Gladys ;
Berg, William J. ;
Kay, Andrea ;
Lebwohl, David ;
Ravaud, Alain .
LANCET, 2008, 372 (9637) :449-456
12